GJCCMAAERJZFFN-OOXUFLSTSA-N
C34H36ClF4N9O3 — CID 138552211
Data last refreshed: (MolForge compound catalog, from PubChem)
About GJCCMAAERJZFFN-OOXUFLSTSA-N
GJCCMAAERJZFFN-OOXUFLSTSA-N (PubChem CID 138552211) has the molecular formula C34H36ClF4N9O3 and a molecular weight of 730.17 g/mol. Its IUPAC name is [(2S)-2-[(4R)-2-amino-4-[4-[1-(difluoromethyl)pyrazol-4-yl]phenyl]-4-(2,2-dimethylpropyl)-5-oxoimidazol-1-yl]-2-[4-chloro-3-[5-(difluoromethyl)-1,2,4-triazol-1-yl]phenyl]ethyl] N-cyclobutylcarbamate.
Molecular Properties
| Compound Name | GJCCMAAERJZFFN-OOXUFLSTSA-N |
|---|---|
| PubChem CID | 138552211 |
| Molecular Formula | C34H36ClF4N9O3 |
| Molecular Weight | 730.17 g/mol |
| Exact Mass | 729.26 |
| IUPAC Name | [(2S)-2-[(4R)-2-amino-4-[4-[1-(difluoromethyl)pyrazol-4-yl]phenyl]-4-(2,2-dimethylpropyl)-5-oxoimidazol-1-yl]-2-[4-chloro-3-[5-(difluoromethyl)-1,2,4-triazol-1-yl]phenyl]ethyl] N-cyclobutylcarbamate |
| SMILES | CC(C)(C)C[C@]1(c2ccc(-c3cnn(C(F)F)c3)cc2)N=C(N)N([C@H](COC(=O)NC2CCC2)c2ccc(Cl)c(-n3ncnc3C(F)F)c2)C1=O |
| InChI | InChI=1S/C34H36ClF4N9O3/c1-33(2,3)17-34(22-10-7-19(8-11-22)21-14-42-46(15-21)30(38)39)29(49)47(31(40)45-34)26(16-51-32(50)44-23-5-4-6-23)20-9-12-24(35)25(13-20)48-28(27(36)37)41-18-43-48/h7-15,18,23,26-27,30H,4-6,16-17H2,1-3H3,(H2,40,45)(H,44,50)/t26-,34-/m1/s1 |
| InChIKey | GJCCMAAERJZFFN-OOXUFLSTSA-N |
| XLogP | 6.93 |
| TPSA | 145.55 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 11 |
| Heavy Atoms | 51 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 730.17 |
| LogP ≤ 5 | 6.93 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 10 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 138552211 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.